STAAR Surgical Soars: Unraveling the Buzz Behind the 13% Surge STAAR Surgical Soars: Unraveling the Buzz Behind the 13% Surge

by Ron Finklestien

Updated On: April 4, 2024 1:44 pm

Taking Flight: STAAR Surgical Shines Bright

Shares of STAAR Surgical Company STAA took flight today, propelled by vigorous preliminary first-quarter net sales guidance.

STAAR Surgical shares ascended 13.3% to $44.30 during the trading session.

Let’s also look at other stocks making waves in today’s mid-day session.

Surging Stars

TC Biopharm (Holdings) Plc TCBP skyrocketed by 130.1% to $2.9790. Their move made waves after the announcement of a non-binding letter of intent for the acquisition of NK Platform Technologies.
Allurion Technologies Inc. ALUR surged by 70% to $2.8801. The company’s market boost followed the launch of its Virtual Care Suite in the United States, alongside a noble Buy rating initiation by Chardan Capital and a peek at a $5 price target.
Tevogen Bio Holdings Inc. TVGN ascended by 40.6% to $3.58. The recent appointment of Tapan V Shah as the Head of Investor Relations and Corporate Development brought brightness to their market performance.
HWH International Inc. HWH rose by 38.8% to $2.1765, shining on the trading floors.
Candel Therapeutics, Inc. CADL radiated a 36.3% increase to $2.2899, illuminating the market post-announcement of interim data from a critical phase 2 clinical trial.
…and the list goes on with many other luminaries in the market sky…

Sliding Under the Radar

eFFECTOR Therapeutics, Inc. EFTR experienced an 80.7% dip to $3.1801. Their decline flew under the radar post the topline results from a significant Phase 2 trial.
Keyarch Acquisition Corporation KYCH stumbled down by 34.5% to $5.94, marking a poignant moment in today’s market landscape.
And the solemn parade of today’s downtrends continues…

Market Meltdown: Stocks Take a Dive Across the Board

View, Inc. VIEW plummeted 29.4% to $0.3601, following the company’s Chapter 11 bankruptcy filing.
Achilles Therapeutics plc ACHL sank 27% to $0.88 post its release of fourth-quarter financial results, unveiling data from the CHIRON and THETIS studies.
KWESST Micro Systems Inc. KWE dropped 24.4% to $0.85 after proposing a US public offering.
AXT, Inc. AXTI nosedived 22.2% to $3.85 on the back of negative reports from J Capital.
XTI Aerospace, Inc. XTIA saw a 20.9% decline to $3.64, after a surprising 31% surge the day before.
DigiAsia Corp. FAAS tumbled 20% to $5.37.
Lamb Weston Holdings, Inc. LW slumped 17.5% to $83.40 post-announcement of disappointing third-quarter results and a revised FY24 outlook.
Selina Hospitality PLC SLNA retreated 17.5% to $0.0811.
Casa Systems, Inc. CASA declined 16.3% to $0.0460 after entering an asset purchase agreement with Lumine.
Kintara Therapeutics, Inc. KTRA fell 15.2% to $0.1390, amid a merger agreement with TuHURA Biosciences.
Flora Growth Corp. FLGC saw a 13.5% decline to $2.3095 after announcing a public share offering.
GCT Semiconductor Holding, Inc. GCTS dropped 13.1% to $5.96.
SolarMax Technology, Inc. SMXT dipped 10.9% to $11.75.
LAMF Global Ventures Corp. I LGVC witnessed a 10.2% decline to $9.97, following a recent gain and business combination announcement with Nuvo.
ARCA biopharma, Inc. ABIO fell 8.9% to $2.96, after a merger announcement with Oruka Therapeutics led to a surge the day prior.
Aquestive Therapeutics, Inc. AQST declined 8.9% to $3.9850 post announcing a $250 million mixed shelf offering.
OneMedNet Corporation ONMD witnessed an 8.6% decrease to $0.97, despite a significant jump following a funding announcement.
Rent the Runway, Inc. RENT fell 8.6% to $5.37.
Paramount Global PARA stumbled 8.2% to $12.40 post a report indicating the need for new equity in an Ellison-led bid.